Alivus Life Sciences - Quaterly Results

01 Aug 2025 Evaluate
The quarter ended June 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 6018.46 millions.Profit saw a slight increase of 9.02%to Rs. 1215.35  millions from Rs. 1114.83 millions.Operating profit for the quarter ended June 2025 rose to 1812.96 millions as compared to 1649.78 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 6018.46 5886.16 2.25 6018.46 5886.16 2.25 23868.84 22832.14 4.54
Other Income 89.85 54.93 63.57 89.85 54.93 63.57 345.70 120.42 187.08
PBIDT 1812.96 1649.78 9.89 1812.96 1649.78 9.89 7171.54 6862.88 4.50
Interest 12.51 3.53 254.39 12.51 3.53 254.39 24.14 15.46 56.14
PBDT 1800.45 1646.25 9.37 1800.45 1646.25 9.37 7147.40 6847.42 4.38
Depreciation 170.64 143.87 18.61 170.64 143.87 18.61 606.09 534.52 13.39
PBT 1629.81 1502.38 8.48 1629.81 1502.38 8.48 6541.31 6312.90 3.62
TAX 414.46 387.55 6.94 414.46 387.55 6.94 1685.04 1604.02 5.05
Deferred Tax 25.10 12.38 102.75 25.10 12.38 102.75 60.64 81.88 -25.94
PAT 1215.35 1114.83 9.02 1215.35 1114.83 9.02 4856.27 4708.88 3.13
Equity 245.26 245.05 0.09 245.26 245.05 0.09 245.07 245.05 0.01
PBIDTM(%) 30.12 28.03 7.48 30.12 28.03 7.48 30.05 30.06 -0.04

Alivus Life Sciences Share Price

883.20 12.60 (1.45%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×